FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to medicine and pharmacology, namely a drug preparation inducing alpha and beta interferon, and may be used for treating acute respiratory viral infections (ARVI). The agent represents 5-hydroxy-4-dimethylaminomethyl-1-cyclohexyl-2methyl-3-ethyloxycarbonylindole hydrochloride.
EFFECT: invention provides intensified antiviral action.
13 tbl
Title | Year | Author | Number |
---|---|---|---|
INTERFERON-INDUCING AGENT FOR TREATING ACUTE RESPIRATORY VIRAL INFECTIONS (ARVD) | 2010 |
|
RU2445094C1 |
DRUG POSSESSING INTERFERON-INDUCING AND IMMUNOMODULATING (IMMUNOSTIMULATING) ACTIVITY | 1987 |
|
RU2033157C1 |
ANTI-VIRAL IMMUNOTROPIC AGENT FOR TREATMENT OF ARVI | 2018 |
|
RU2672888C1 |
AGENT SHOWING EFFECT WITH RESPECT TO INFECTIOUS AGENTS | 1994 |
|
RU2092177C1 |
INTERFERON INDUCING AGENT | 1998 |
|
RU2132681C1 |
PROLONGED-EFFECT INTERFERON INDUCTOR | 1999 |
|
RU2172631C2 |
USE OF LIOPHILISED PREPARATION OF ALLOFIBROBLASTS FOR TREATING HERPES VIRUS DISEASES | 2012 |
|
RU2483739C1 |
METHOD AND MEANS FOR STIMULATING RESISTANCE TO INFECTION | 2001 |
|
RU2191594C1 |
ANTIVIRAL AGENT | 2014 |
|
RU2564919C1 |
DRUG FOR TREATMENT OF PATIENTS WITH VIRAL DISEASE | 1994 |
|
RU2118163C1 |
Authors
Dates
2012-12-27—Published
2010-10-05—Filed